Filter
770
Text search:
Post-exposure
prophylaxis
Featured
Recommendations
85
New Publications
241
Language
Document type
No document type
493
Guidelines
137
Studies & Reports
60
Manuals
26
Strategic & Response Plan
21
Fact sheets
14
Training Material
9
Infographics
4
Resource Platforms
3
Situation Updates
2
Online Courses
1
Countries / Regions
India
40
South Africa
33
Kenya
26
Tanzania
25
Zambia
23
Global
21
Uganda
19
Nigeria
17
Namibia
17
Malawi
16
Liberia
15
Lesotho
13
Nepal
12
Rwanda
12
Sierra Leone
11
Ethiopia
11
Africa
10
Ghana
9
Philippines
8
Myanmar / Burma
8
Bangladesh
7
Zimbabwe
5
Cambodia
5
Ukraine
5
Botswana
5
Western and Central Europe
5
Asia
5
Germany
4
Latin America and the Carribbean
4
South Sudan
3
Syria
3
Madagascar
3
Paraguay
3
Eastern Europe
3
Georgia
3
Argentina
2
Eswatini/ Swaziland
2
Yemen
2
South–East Asia Region
2
Western Pacific Region
2
Laos
2
Burkina Faso
1
Congo, Democratic Republic of
1
Cameroon
1
Haiti
1
Pakistan
1
Lebanon
1
Indonesia
1
Mozambique
1
Central African Republic
1
East and Southern Africa
1
West and Central Africa
1
Middle East and North Africa
1
Solomon Islands
1
Armenia
1
Southern Africa
1
Tajikistan
1
Russia
1
Romania
1
Vietnam
1
Authors & Publishers
Publication Years
Category
Countries
335
Clinical Guidelines
73
Women & Child Health
47
Key Resources
33
Public Health
32
Capacity Building
8
Pharmacy & Technologies
6
Toolboxes
HIV
207
NTDs
35
Rapid Response
22
Ebola & Marburg
21
COVID-19
18
Pharmacy
18
TB
15
Caregiver
14
Mental Health
13
Conflict
11
Planetary Health
9
Refugee
7
Disability
5
AMR
5
Health Financing Toolbox
4
2.0 Rapid Response
4
Specific Hazards
3
Global Health Education
3
Polio
2
NCDs
2
Malaria
2
Natural Hazards
1
WHO recommends that pre-exposure prophylaxis (PrEP) be offered as an additional prevention choice for HIV-negative individuals at substantial risk of HIV infection as part of combination prevention approaches.
HIV drug resistance has been rarely
...
Offering additional pre-exposure prophylaxis (PrEP) choices has the potential to increase uptake and effective use of PrEP, and of HIV prevention overall, as it allows people to choose a method that they prefer.
In this guideline, WHO recommends
...
These guidelines provide evidence-based guidance on the use of peripartum antiviral prophylaxis in HBsAg-positive pregnant women for the prevention of mother-to-child transmission of HBV.
Guidelines on lenacapavir for HIV prevention and testing strategies for long-acting injectable pre-exposure prophylaxis. Web Annex B
SADC Communicable Disease Project
Component 5: Scaling-up Child and Adolescent HIV, TB and Malaria Continuum of Care and Support
DRAFT POST REGIONAL CONSENSUS AND VALIDATION MEETING Oct 2012
This document provides technical guidance on concepts, definitions, indicators, criteria, milestones and tools to assist leprosy programmes in their journey towards the goals of interruption of transmission and elimination of leprosy disease and through the post-elimination period. Importantly, it p
...
The South African WHO Country Cooperation Strategy (CCS) 2023–2027 focuses on four key strategic priorities based on the country’s health needs and disease epidemiology, while also considering the need for building resilient health systems for UHC and health security in the post pandemic period.
...
3 June 2021. After 40 years of AIDS, charting a course to end the pandemic.
The report shows that countries with progressive laws and policies and strong and inclusive health systems have had the best outcomes against HIV. In those countries, people living with and affected by HIV are more likely t
...
Adolescent girls and young women (AGYW) remain disproportionately affected by HIV in Eastern and Southern Africa (ESA), with 26 per cent of new infections attributed to this population. AGYW face many personal, social and structural barriers to access, uptake and use of traditional HIV prevention me
...
Interim rapid response guidance, 10 June 2022.
It includes considerations for certain populations such as patients with mild disease with considerations for community care, patients with moderate to severe disease, sexually active persons, pregnant or breastfeeding women, children and young persons
...
